PL1660009T3 - Sposoby leczenia endometriozy - Google Patents

Sposoby leczenia endometriozy

Info

Publication number
PL1660009T3
PL1660009T3 PL04769463T PL04769463T PL1660009T3 PL 1660009 T3 PL1660009 T3 PL 1660009T3 PL 04769463 T PL04769463 T PL 04769463T PL 04769463 T PL04769463 T PL 04769463T PL 1660009 T3 PL1660009 T3 PL 1660009T3
Authority
PL
Poland
Prior art keywords
endometriosis
treatment
methods
Prior art date
Application number
PL04769463T
Other languages
English (en)
Inventor
Mirudhubashini Bovindarajan
Original Assignee
Miscon Trading S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miscon Trading S A filed Critical Miscon Trading S A
Publication of PL1660009T3 publication Critical patent/PL1660009T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
PL04769463T 2003-09-03 2004-08-27 Sposoby leczenia endometriozy PL1660009T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50021703P 2003-09-03 2003-09-03
US52635503P 2003-12-01 2003-12-01
PCT/IB2004/003103 WO2005020880A2 (en) 2003-09-03 2004-08-27 Methods for the treatment of endometriosis
EP04769463.3A EP1660009B1 (en) 2003-09-03 2004-08-27 Methods for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
PL1660009T3 true PL1660009T3 (pl) 2015-08-31

Family

ID=34278698

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04769463T PL1660009T3 (pl) 2003-09-03 2004-08-27 Sposoby leczenia endometriozy

Country Status (22)

Country Link
US (2) US9532995B2 (pl)
EP (2) EP2617411A1 (pl)
JP (2) JP5651279B2 (pl)
KR (2) KR101285137B1 (pl)
CN (1) CN101849906A (pl)
AU (1) AU2004267956B2 (pl)
BR (1) BRPI0413200A (pl)
CA (1) CA2537702C (pl)
DK (1) DK1660009T3 (pl)
EA (1) EA015356B1 (pl)
ES (1) ES2535430T3 (pl)
HK (1) HK1095529A1 (pl)
HR (1) HRP20150440T1 (pl)
HU (1) HUE025239T2 (pl)
IL (1) IL174014A0 (pl)
MA (1) MA28083A1 (pl)
NO (1) NO20061502L (pl)
PL (1) PL1660009T3 (pl)
PT (1) PT1660009E (pl)
SI (1) SI1660009T1 (pl)
TN (1) TNSN06070A1 (pl)
WO (1) WO2005020880A2 (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
WO2009140126A1 (en) * 2008-05-14 2009-11-19 Juneau Biosciences, Llc Method of administering a therapeutic
WO2010124101A2 (en) 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
EP2471537A1 (en) * 2010-12-30 2012-07-04 PregLem S.A. Treatment of pain associated with dislocation of basal endometrium
AR082266A1 (es) * 2011-05-13 2012-11-28 Univ Nac Del Litoral Microparticula inyectable de liberacion controlada
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015073066A1 (en) * 2013-11-12 2015-05-21 University Of Utah Research Foundation Glycol chitin based thermosensitive hydrogel for vaginal delivery of progesterone
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US20190298771A1 (en) * 2016-09-28 2019-10-03 Atossa Genetics Inc. Methods of adoptive cell therapy
RU2661701C1 (ru) * 2017-02-09 2018-07-19 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Способ лапароскопического лечения узловых форм аденомиоза
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2021173373A1 (en) * 2020-02-26 2021-09-02 Fordoz Pharma Corp. Injectable controlled-release formulations of progestogen drugs
RU2746476C1 (ru) * 2020-04-28 2021-04-14 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ хирургического лечения глубокого инфильтративного эндометриоза ректовагинальной перегородки
GB2594726A (en) * 2020-05-05 2021-11-10 Nadezhda Reproductive Science Ood Adenomyosis associated infertility and HDACIs

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038A (en) 1845-05-10 Boot-crimp
US61303A (en) * 1867-01-15 James yocom
US5362A (en) 1847-11-06 Ice-ctjttee
US5543A (en) 1848-05-02 of jbesey city
US720A (en) 1838-04-28 Improved mode of forming a kiln for making charcoal
US389A (en) 1837-09-21 Mode of supporting the bodies of railroad-cars and carriages
US150A (en) 1837-03-25 Island
US12703A (en) * 1855-04-10 Gabhst-chaie
US3089815A (en) * 1951-10-11 1963-05-14 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
GB784659A (en) 1954-11-26 1957-10-16 Upjohn Co Therapeutic compositions and aqueous suspensions thereof
US4038389A (en) * 1975-05-07 1977-07-26 The Upjohn Company Medroxyprogesterone acetate compositions
FR2663223B1 (fr) 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
GB2252497B (en) 1991-02-04 1995-01-18 Elsimar Metzker Coutinho Pharmaceutical composition
JPH0735335B2 (ja) 1991-02-28 1995-04-19 五十嵐 正雄 子宮内膜症の治療薬
HU222501B1 (hu) 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
RU2073534C1 (ru) 1993-06-04 1997-02-20 Сочинский научно-исследовательский институт курортологии и физиотерапии МЗ РФ Способ лечения генитального эндометриоза
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
EP0792152B1 (en) * 1994-11-22 2004-04-14 Balance Pharmaceuticals, Inc. Methods of contraception
EP0785212A1 (en) 1996-01-22 1997-07-23 Laboratoire Theramex New 19-nor-pregnene derivatives
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6265393B1 (en) * 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
JP2002525268A (ja) * 1998-09-16 2002-08-13 オンコファーマシューティカル， インコーポレイテッド ゴルジ装置妨害剤の注射可能な処方物での腫瘍学的腫瘍の処置
WO2000021511A2 (en) 1998-10-09 2000-04-20 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
JP2001051773A (ja) * 1999-08-16 2001-02-23 Toshiaki Matsuhashi キーボードカバー
US6613355B2 (en) * 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
AU2001262228A1 (en) 2000-05-15 2001-11-26 Pharmacia Italia S.P.A. Stabilized steroidal suspension
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
AU2001296558A1 (en) 2000-10-03 2002-04-15 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
US20020072509A1 (en) * 2000-10-11 2002-06-13 Stein Donald Gerald Methods for the treatment of a traumatic central nervous system injury
IL157531A0 (en) * 2001-02-23 2004-03-28 Genentech Inc Erodible polymers for injection
JP4273208B2 (ja) * 2001-03-30 2009-06-03 チッソ株式会社 婦人科疾患治療剤
US20040105889A1 (en) * 2002-12-03 2004-06-03 Elan Pharma International Limited Low viscosity liquid dosage forms

Also Published As

Publication number Publication date
US20150044291A1 (en) 2015-02-12
KR101285137B1 (ko) 2013-07-11
BRPI0413200A (pt) 2006-10-03
PT1660009E (pt) 2015-05-18
KR20120005062A (ko) 2012-01-13
CA2537702C (en) 2012-01-03
EP1660009B1 (en) 2015-01-28
ES2535430T3 (es) 2015-05-11
EP1660009A4 (en) 2010-02-17
US9468647B2 (en) 2016-10-18
KR101288265B1 (ko) 2013-07-26
JP5651279B2 (ja) 2015-01-07
MA28083A1 (fr) 2006-08-01
EA200600524A1 (ru) 2006-08-25
KR20070017946A (ko) 2007-02-13
EP1660009A2 (en) 2006-05-31
HUE025239T2 (en) 2016-03-29
US9532995B2 (en) 2017-01-03
CA2537702A1 (en) 2005-03-10
US20050085453A1 (en) 2005-04-21
DK1660009T3 (en) 2015-04-27
SI1660009T1 (sl) 2015-07-31
WO2005020880A2 (en) 2005-03-10
JP2013035866A (ja) 2013-02-21
CN101849906A (zh) 2010-10-06
HK1095529A1 (en) 2007-05-11
NO20061502L (no) 2006-06-02
AU2004267956B2 (en) 2010-09-16
AU2004267956A1 (en) 2005-03-10
WO2005020880A3 (en) 2006-05-26
JP2007509032A (ja) 2007-04-12
HRP20150440T1 (hr) 2015-07-03
EP2617411A1 (en) 2013-07-24
EA015356B1 (ru) 2011-06-30
TNSN06070A1 (en) 2007-10-03
IL174014A0 (en) 2006-08-01

Similar Documents

Publication Publication Date Title
IL174014A0 (en) Methods for the treatment of endometriosis
EP1613308A4 (en) CANCER TREATMENT METHODS
EP1689485A4 (en) CARDIOELECTROMAGNETIC TREATMENT
EP1666016A4 (en) TREATMENT UNIT
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
HRP20150163T1 (en) Process for the preparation of n-substituted 2-cyanopyrrolidines
GB0326486D0 (en) Combination treatment
EP1677816A4 (en) THERAPEUTIC METHOD
GB0312407D0 (en) Treatment
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
GB0401495D0 (en) Well treatment system
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
EP1648469A4 (en) ANTIGLUCOCORTICOIDES FOR THE TREATMENT OF CATATONIA
GB0327975D0 (en) Methods of treatment
GB0307544D0 (en) Treatment method
HK1087111A1 (en) Process for the preparation of nicotinaldehydes
GB0302691D0 (en) Treatment method
EP1638573A4 (en) USE OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS FOR THE TREATMENT OF ENDOMETRIOSIS
HU0300255D0 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine
GB0303430D0 (en) Treatment methods
GB0315322D0 (en) Treatment methods
GB0322921D0 (en) Methods of treatment
GB0324482D0 (en) Methods for the treatment of cancer
GB0328650D0 (en) Treatment equines
GB0307740D0 (en) Treatment